BIIB Related Insiders' Blog
-
Biogen Idex (BIIB) CEO Scangos Says New MS Treatment Will Bolster Offerings
-
Elan (ELN), Novartis (NVS) Tick Higher on PDUFA Extension for Biogen's (BIIB) MS PillBG-12
-
Q2 Kickoff: Alcoa (AA) Investors to Focus on LME Prices, Downstream Ops, and China
-
Traders Watching Regeneron (REGN) Following Amgen (AMGN) AMG 145 Results
-
Cramer Pounds the Table on Biogen Idec (BIIB) Ahead of BG-12 Filing
-
Corporate Earnings for Q1 Look Promising So Far, Here's the Top Movers...
-
Carl Icahn Shows New Stakes In Energy Names and a Gun Maker (APC, NRG, SWHC)
-
Wall Street Hubbub 7/26: A Genzyme (GENZ) Deal Coming, Is Biogen Idec (BIIB) Next, New BP CEO, Goldman Sachs the Movie
-
Wall Street Hubbub 7/21: Traders Nervous Ahead NFLX/BIDU Results, Dimon & Blankfein Not Welcome at FinReg Signing, Bernanke Set to Testify, BIIB/LLL/DTG In the Rumor Mill
-
Genzyme (GENZ) Creeps Higher On Potential Biotech Mega-Deal
-
A Stock Picker Hits His Stride
-
Icahn Gets Another Seat on Biogen (BIIB) Board
-
'Takeover Fever' Continues In Biotech After Facet (FACT) Deal, Who's Next?
-
Biogen Idec (BIIB) Up On Renewed Takeover Speculation
-
Carl Icahn Raises Stakes In Take-Two (TTWO) and Genzyme (GENZ), Slashes Stake in Yahoo! (YHOO)
-
Morgan Stanley Gives a Preview for Biotech's Q4 Earnings (GILD, CELG, BIIB, GENZ, More...)
-
Elan (ELN) and Biogen (BIIB) Weak On Jump In Tysabri PML Cases
-
Merriman Curhan Pounds The Table On Facet Biotechnology (FACT) After Board Formally Rejects Biogen Offer
-
Stocks That Could Rise As Cases Of The Swine Flu Increase (RAD, GENZ, GILD, UTHR, XRAY)
-
Icahn's 13Fs Show No Major Changes (YHOO, MOT, BIIB, AMLN, LGF)
-
Report J&J's Deal With Elan Could Turn Its Attention Toward Biogen (BIIB)
-
Sanofi-Aventis (SNY) On the Prowl For A Mega-Deal In the U.S.?
-
Icahn Says Future Is Big Pharma Will Buy Biotech (BIIB, AMLN)
-
Icahn To File Lawsuit To Stop Biogen Idec (BIIB) Vote
-
Icahn Boosts Stake in American Railcar (ARII), Maintains Large Yahoo! (YHOO) and Motorola (MOT) Holdings
-
Elan (ELN) Up Following Positive TYSABRI Study Results On Reversing MS Damage
-
Icahn Raises Stakes In AMLN, LGF, WMB, YHOO; Cuts Stakes in TIN, LEA
-
Reports Sanofi-Aventis (SNY) On The Prowl For Mergers
-
Low Investor Sentiment Provides Buying Opportunity in Biogen (BIIB) -BWS Financial
-
Icahn Down $60M on Healthcare Stocks This Week (AMLN, BIIB, CYBX, REGN, FOLD)
-
Icahn's Icahn Capital Bumps Stake in Motorola (MOT), Shows New Small Stake in Emisphere (EMIS)
-
Icahn Boosts Stake in Biogen Idec (BIIB) to 6% Following TYSABRI Sell-Off
-
Elan (ELN) and Biogen (BIIB) Sink After Disclosing Two Additional TYSABRI-Related PML Cases
-
Biotech Takeover Buzz Hot and Heavy After ImClone Offer (ONXX, OSIP, BIIB, AMLN, XPNT, CYPB, ISPH)
-
Amylin Pharmaceuticals (AMLN) Could Be One To Watch On ImClone Bid
-
Biogen Idec (BIIB) Could Be One To Watch On ImClone Bid
-
Icahn's Icahn Capital Boosts Stake in Biogen (BIIB) to Nearly 10M Shares
-
Summary of Icahn Capital 13F; New Stake In JCP, Ups Stakes in APC, M
-
Icahn Has a Busy Day: BEAS, WCI, More...
-
What's A Fair Price for Biogen Idec (BIIB) To Trade At?
-
Could Icahn Target Biogen Idec (BIIB) Next?
-
Will BIIB Bounce After Today's Disaster?
Back to BIIB Stock Lookup
